The Supreme Court on Monday posed some tough questions to a lawyer, asking him to substantiate his "unfounded allegations" in a PIL that Indian pharma major Ranbaxy Laboratories Ltd was allegedly manufacturing and selling adulterated medicines.
Company is among the few companies in the sector getting pulled up by FDA for violations at its factories in India.
Farmers said a big reason for the anger was the sudden stopping of wheat procurement by the state government in some places, which had caused the prices to dip below the minimum support price.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
If RBI has to replace the entire stock of Rs 1,000 and Rs 500 notes with Rs 100 ones, the cost would be more than Rs 10,000 crore.
While it took the Congress nearly a half century to earn the hatred of other political outfits, the BJP appears set to reach there in around six years, says Arun Bhatnagar, former secretary to the GoI.
The NIA's chargesheet in the 2006 Malegaon blasts mocks the investigation conducted by the Maharashtra Anti-Terrorism Squad into the matter, reports Vicky Nanjappa
Brokerages have cut the company's FY16 earnings estimates between 16% and 29% with target prices too coming down to the Rs 700-800 band
In May this year, Ranbaxy had pleaded guilty to 'felony charges' for violating manufacturing norms and agreed to pay $500 million penalty to US authorities.
A source said the competition watchdog would by next month suggest 'structural remedies' that included selling key drug segments as conditions for clearing the country's largest pharmaceutical industry merger.
A day after getting a show-cause notice from the Indian regulator, senior executives from Ranbaxy Laboratories approached the drug controller's office on Tuesday afternoon, it was learnt.
The Lok Sabha election will be held in 7 phases, beginning on April 11, 2019 and ending on May 19, 2019.
The PIL , filed by advocate M L Sharma, sought action against Ranbaxy for allegedly supplying substandard and adulterated drugs
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
Pipliyamandi becomes the epicentre of the current farmers' agitation across the country, demanding better price for their produce and loan waiver and a political hot-potato for all.
Sun Pharma expects synergy benefits by next fiscal.
Sun Pharma would have to do a lot of work to get USFDA to revoke the ban on Ranbaxy facilities but it has not put any time-frame for this, company ChairmanIsrael Makov said.
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
This classification of districts is to be followed by states and union terrotories till a week post May 3, when the second phase of lockdown will end, for containment operations.
The VHP will focus on non-religious topics and give the Ram temple a miss at the three-day Vaicharik Kumbh, to be attended by Prime Minister Narendra Modi. Shashikant Trivedi reports.
The government on Monday countered the Congress charges of snooping on Rahul Gandhi saying it was making a "mountain out of what is not even a molehill" as information collection was part of a transparent security profiling used on 526 VIPs, including Sonia Gandhi and former prime ministers.
The NIA has found nothing to suggest that Sadhvi Pragya Singh Thakur and 3 others were involved in Malegaon and Samjhauta blasts accused Sunil Joshi's murder, reports Vicky Nanjappa.
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
James Wilson tracks down discrepancies in the much-hailed demonetisation policy and the subsequent statements of the government and the Reserve Bank of India.
'Most of the agitations are staged by the Opposition to disturb the peace of the state.'
Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.
FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain
The Halol facility is important for the company as it accounts for 10 per cent of Sun Pharma's sales.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
In the first of a four-part series, Business Standard takes a look at how a mint in Salboni, West Bengal, is working overtime to print currency notes.
'My grandmother taking me to the jamatkhana was like a different world.' 'Like I had a key to a door which no one else seemed to have.' 'She doesn't take me anymore because she says I'm an embarrassment!'
The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.
Modi can waive loans of the country's rich but can't do the same for farmers, he said.
The crux of the problem is change, specifically the Rs 500 note, which India's presses cannot, currently, print in adequate number, says Sahil Kini/IndiaSpend.
Many countries advised the return the high-denomination notes to the central bank for destruction, but these continued to be legal tender. This and the introduction of a new Rs 2,000 note in India are the two major differences between Indian demonetisation and those of other countries.
James Wilson explains why Indians are destined to silently suffer the cash shortage for half a dozen more months.
As the dust finally settles on the outcome of the Lok Sabha elections 2019 and Bharatiya Janata Party along with its NDA allies emerges as the clear winner, here is a list of who won in each of the 7 phases of elections.
The minister tells Subhomoy Bhattacharjee that he wants to set up a financing corporation for the road and shipping sectors, which will throw up a business opportunity of Rs 25 lakh crore!
Opposition parties in Parliament on Monday vociferously protested the "snooping" on Rahul Gandhi, with the government dismissing their contention saying they were making a "mountain out of what is not even a molehill", leading the Congress to walk out of Rajya Sabha.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances